Business Context and Reporting Period
This Form 6-K filing is submitted by Hexindai Inc., a foreign private issuer, for the month of August 2020. The report was signed by Zhang Rui (Kerrie), Chief Financial Officer, on August 10, 2020. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing includes a press release as Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific financial data. There are no disclosed values for revenue, profit, cash flow, margins, debt, or liquidity within this document.
Material Changes
The filing text does not provide information regarding material changes compared to prior periods.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, risk factors, contingencies, or details on unusual items. The content is limited to the cover page, signature block, and exhibit index.
Investor Verification Checklist
- Verify the content of the attached Press Release (Exhibit 99.1) for specific operational or financial updates.
- Confirm the discrepancy between the requested company name "Akso Health Group" and the registrant name "Hexindai Inc." listed in the filing.
- Review the full Form 20-F annual report for comprehensive financial statements, as this Form 6-K contains no numerical data.